FGFR2 promotes breast tumorigenicity through maintenance of breast tumor-initiating cells.
Kim S, Dubrovska A, Salamone RJ, Walker JR, Grandinetti KB, Bonamy GM, Orth AP, Elliott J, Porta DG, Garcia-Echeverria C, et al. PLoS One. 2013; 8(1):e51671. Epub 2013 Jan 2.